You just read:

Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference

News provided by

Regeneron Pharmaceuticals, Inc.

May 18, 2015, 12:30 ET